biblio

Export 140 results:
Filters: Author is Sarkar, Dhiman  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
E
S. Waghmode, Swami, S., Sarkar, D., Suryavanshi, M., Roachlani, S., Choudhari, P., and Satpute, S., “Exploring the pharmacological potentials of biosurfactant derived from planococcus maritimus SAMP MCC 3013”, Current Microbiology, vol. 77, no. 3, pp. 452-459, 2020.
S. P. Gample, Agrawal, S., and Sarkar, D., “Evidence of nitrite acting as a stable and robust inducer of non-cultivability in Mycobacterium tuberculosis with physiological relevance”, Scientific Reports, vol. 9, p. 9261, 2019.
D. D. Subhedar, Shaikh, M. H., Nawale, L., Yeware, A., Sarkar, D., and Shingate, B. B., “[Et3NH][HSO4] catalyzed efficient synthesis of 5-arylidene-rhodanine conjugates and their antitubercular activity”, Research on Chemical Intermediates, vol. 42, no. 8, pp. 6607-6626, 2016.
L. Nawale and Sarkar, D., “Efficacy study of potential anti-tubercular molecules: in-vitro and ex-vivo”, in National Science Day, National Chemical Laboratory, Pune 411008, 2015.
D
G. Navale, Singh, S., Agrawal, S., Ghosh, C., Choudhury, A. Roy, Roy, P., Sarkar, D., and Ghosh, K., “DNA binding, antitubercular, antibacterial and anticancer studies of newly designed piano-stool ruthenium(ii) complexes”, Dalton Transactions, vol. 51, no. 42, pp. 16371-16382, 2022.
L. Nawale and Sarkar, D., “Discovery of new chemical entities against diseases of national importance :an HTS approach”, in National Science Day, At CSIR-NCL, Combi Chem-Bio Resource Center, OCD, National Chemical Laboratory, Pune - 411 008, 2015.
U. Singh and Sarkar, D., “Development of a simple high-throughput screening protocol based on biosynthetic activity of Mycobacterium tuberculosis glutamine synthetase for the identification of novel inhibitors”, Journal of Biomolecular Screening, vol. 11, no. 8, pp. 1035-1042, 2006.
U. Singh, Panchanadikar, V., and Sarkar, D., “Development of a simple assay protocol for high-throughput screening of mycobacterium tuberculosis glutamine synthetase for the identification of novel inhibitors”, Journal of Biomolecular Screening, vol. 10, no. 7, pp. 725-729, 2005.
S. Sarkar, Swami, S., Soni, S. Kumar, Holien, J. K., Khan, A., Korwar, A. M., Likhite, A. P., Joshi, R. A., Joshi, R. R., and Sarkar, D., “Detection of a target protein (GroEl2) in Mycobacterium tuberculosis using a derivative of 1,2,4-triazolethiols”, Molecular Diversity, vol. 26, no. 5, pp. 2535-2548, 2022.
R. Gawali, Trivedi, J., Bhansali, S., Bhosale, R., Sarkar, D., and Mitra, D., “Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted-2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors”, European Journal of Medicinal Chemistry, vol. 157, pp. 310-319, 2018.
S. Gholap, Tambe, M., Nawale, L., Sarkar, D., Sangshetti, J., and Damale, M., “Design, synthesis, and pharmacological evaluation of fluorinated azoles as anti-tubercular agents”, Archiv Der Pharmazie, vol. 351, no. 2, p. e1700294, 2018.
R. Mamgain, Swami, S., Sarkar, D., and Srivastava, P., “Design, synthesis, and in vitro biological evaluation of ROS-generating phenanthridin-trione-epoxide conjugates as agents against mycobacterium tuberculosis”, ChemistrySelect, vol. 8, no. 25, p. e202300416, 2023.
M. S. Tambe, Choudhari, A., Sarkar, D., Sangshetti, J., Patil, R., and Gholap, S. S., “Design, synthesis and biological screening of novel 1,3,4-oxadiazoles as antitubercular agents”, Chemistryselect, vol. 3, no. 47, pp. 13304-13310, 2018.
P. K. Gadekar, Roychowdhury, A., Kharkar, P. S., Khedkar, V. M., Arkile, M. A., Manek, H., Sarkar, D., Sharma, R., Vijayakumar, V., and Sarveswari, S., “Design, synthesis and biological evaluation of novel azaspiro analogs of linezolid as antibacterial and antitubercular agents”, European Journal of Medicinal Chemistry, vol. 122, pp. 475-487, 2016.
A. Atmaram Upare, Gadekar, P. K., Sivaramakrishnan, H., Naik, N., Khedkar, V. M., Sarkar, D., Choudhari, A., and S. Roopan, M., “Design, synthesis and biological evaluation of (E)-5-styryl-1,2,4-oxadiazoles as anti-tubercular agents”, Bioorganic Chemistry, vol. 86, pp. 507-512, 2019.
S. Singh, Navale, G. R., Agrawal, S., Singh, H. Kisan, Singla, L., Sarkar, D., Sarma, M., Choudhury, A. Roy, and Ghosh, K., “Design and synthesis of piano-stool ruthenium(II) complexes and their studies on the inhibition of amyloid ? (1-42) peptide aggregation”, International Journal of Biological Macromolecules, vol. 239, p. 124197, 2023.
A. C. Lele, Raju, A., Khambete, M. P., Ray, M. K., Rajan, M. G. R., Arkile, M. A., Jadhav, N. J., Sarkar, D., and Degani, M. S., “Design and synthesis of a focused library of diamino triazines as potential mycobacterium tuberculosis DHFR inhibitors”, ACS Medicinal Chemistry Letters, vol. 6, no. 11, pp. 1140-1144, 2015.
M. A. Wagh, Baravkar, S. B., Jedhe, G. S., Borkute, R., Choudhari, A. S., Sarkar, D., and Sanjayan, G. J., “Design and synthesis of 2-amino-thiophene-tethered ureidopenicillin analogs with potentantibacterial and antitubercular activity”, ChemistrySelect, vol. 3, no. 11, pp. 3122-3126, 2018.
S. B. Baravkar, Wagh, M. A., Nawale, L. U., Choudhari, A. S., Bhansali, S., Sarkar, D., and Sanjayan, G. J., “Design and synthesis of 2-amino-thiophene-proline-conjugates and their anti-tubercular activity against mycobacterium tuberculosis H37Ra”, ChemistrySelect, vol. 4, no. 9, pp. 2851-2857, 2019.
V. S. Pore, Divse, J. M., Charolkar, C. R., Nawale, L. U., Khedkar, V. M., and Sarkar, D., “Design and synthesis of 11 alpha-substituted bile acid derivatives as potential anti-tuberculosis agents”, Bioorganic & Medicinal Chemistry Letters, vol. 25, no. 19, pp. 4185-4190, 2015.
D. D. Subhedar, Shaikh, M. H., Nagargoje, A. A., Sarkar, D., Khedkar, V. M., and Shingate, B. B., “[DBUH][OAc]-catalyzed domino synthesis of novel benzimidazole incorporated 3,5-Bis (Arylidene)-4-piperidones as potential antitubercular agents”, Polycyclic Aromatic Compounds, vol. 42, no. 10, pp. 7010-7024, 2022.
C
N. C. Desai, Bhatt, K., Jadeja, D. J., Mehta, H. K., Khedkar, V. M., and Sarkar, D., “Conventional and microwave-assisted organic synthesis of novel antimycobacterial agents bearing furan and pyridine hybrids”, Drug Development Research, vol. 83, no. 2, pp. 416-431, 2022.
A. S. Kotmale, Sangtani, E., Gonnade, R. G., Sarkar, D., Burade, S., Rajamohanan, P. R., and Sanjayan, G. J., “Conformational studies of Ant-Pro motif-incorporated cyclic peptides: gramicidin S and avellanin”, New Journal of Chemistry, vol. 42, no. 2, pp. 1197-1201, 2018.
P. V. Chavan, Pandit, K. S., Desai, U. V., Wadgaonkar, P. P., Nawale, L., Bhansali, S., and Sarkar, D., “Click-chemistry-based multicomponent condensation approach for design and synthesis of spirochromene-tethered 1,2,3-triazoles as potential antitubercular agents”, Research on Chemical Intermediates, vol. 43, no. 10, pp. 5675-5690, 2017.
, ,, Wadgaonkar, P. P., Tapase, S. R., Kodam, K. M., Choudhari, A., and Sarkar, D., “Click chemistry based multicomponent approach in the synthesis of spirochromenocarbazole tethered 1,2,3-triazoles as potential anticancer agents”, Bioorganic Chemistry, vol. 85, pp. 475-486, 2019.
R. Singh, Nawale, L. U., Arkile, M. A., Shedbalkar, U. U., Wadhwani, S. A., Sarkar, D., and Chopade, B. Ananda, “Chemical and biological metal nanoparticles as antimycobacterial agents: a comparative study”, International Journal of Antimicrobial Agents, vol. 46, no. 2, pp. 183-188, 2015.
N. Tiwari, Nawale, L. U., Sarkar, D., and Badiger, M. V., “Carboxymethyl cellulose-grafted mesoporous silica hybrid nanogels for enhanced cellular uptake and release of curcumin”, Gels, vol. 3, no. 1, 2017.
B
A. Khan, Sarkar, S., and Sarkar, D., “Bactericidal activity of 2-nitroimidazole against the active replicating stage of mycobacterium bovis BCG and mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages”, International Journal of Antimicrobial Agents, vol. 32, no. 1, pp. 40-45, 2008.
A
P. Nigam, Waghmode, S. A., Yeware, A. M., Nawale, L. U., Dagde, P., Dudhane, A., and Sarkar, D., “Aptamer functionalized multifunctional fluorescent nanotheranostic platform for pancreatic cancer”, Journal of Nanopharm Drug Delivery, 2014.
L. Nawale, Dubey, P., Chaudhari, B., Sarkar, D., and Prabhune, A., “Anti-proliferative effect of novel primary cetyl alcohol derived sophorolipids against human cervical cancer cells HeLa”, Plos One, vol. 12 , no. 4, p. e0174241, 2017.
A. A. Chinchansure, Shamnani, N., Arkile, M. A., Sarkar, D., and Joshi, S. P., “Antimycobacterium activity of coumarins from fruit pulp of aegle marmelos (L.) correa”, International Journal of Basic and Applied Chemical Sciences, vol. 5, no. 3, pp. 39-44, 2015.
R. R. Kulkarni, Shurpali, K., Puranik, V. G., Sarkar, D., and Joshi, S. P., “Antimycobacterial labdane diterpenes from leucas stelligera”, Journal of Natural Products, vol. 76, no. 10, pp. 1836-1841, 2013.
R. R. Kulkarni, Tupe, S. G., Gample, S. P., Chandgude, M. G., Sarkar, D., Deshpande, M. V., and Joshi, S. P., “Antifungal dimeric chalcone derivative kamalachalcone E from Mallotus philippinensis”, Natural Product Research, vol. 28, no. 4, pp. 245-250, 2014.
S. B. Nadhe, Tawre, M. S., Agrawal, S., Chopade, B. A., Sarkar, D., and Pardesi, K., “Anticancer potential of AgNPs synthesized using acinetobacter sp. and curcuma aromatica against HeLa cell lines: a comparative study”, Journal of Trace Elements in Medicine and Biology, vol. 62, p. 126630, 2020.
G. S. Bhosle, Nawale, L., Yeware, A. M., Sarkar, D., and Fernandes, M., “Antibacterial and anti-TB tat-peptidomimetics with improved efficacy and half-life”, European Journal of Medicinal Chemistry, vol. 152, pp. 358-369, 2018.
S. Akhtar, Singh, S., Kumar, S., and Sarkar, D., “Analyzing different acetyl co-a metabolizing enzymes as potential drug targets against mycobacterium tuberculosis”, British Microbiology Research Journal, vol. 10, no. 4, pp. 1-15, 2015.
D. D. Subhedar, Shaikh, M. H., Nagargoje, A. A., V. Akolkar, S., Bhansali, S. G., Sarkar, D., and Shingate, B. B., “Amide-linked monocarbonyl curcumin analogues: efficient synthesis, antitubercular activity and molecular docking study”, Polycyclic Aromatic Compounds, vol. 45, no. 5, pp. 2655-2671, 2022.
K. Dilip Shurpali, Singh, U., Sarkar, S. Akhtar Sam, Mishra, A., Kulkarni, R., Joshi, S. P., and Sarkar, D., “Advanced cell-based high-throughput screening assays targeting active and latent Mycobacterium tuberculosis”, Journal of Biotechnology, vol. 185, p. S18, 2014.
2
R. Balasaheb Aher and Sarkar, D., “2D-QSAR modeling and two-fold classification of 1,2,4-triazole derivatives for antitubercular potency against the dormant stage of Mycobacterium tuberculosis”, Molecular Diversity, vol. 26, no. 2, pp. 1227-1242, 2021.
1
M. H. Shaikh, Subhedar, D. D., Nawale, L., Sarkar, D., Khan, F. A. Kalam, Sangshetti, J. N., and Shingate, B. B., “1,2,3-Triazole derivatives as antitubercular agents: synthesis, biological evaluation and molecular docking study”, MedChemComm, vol. 6, no. 6, pp. 1104-1116, 2015.

Pages